These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14804087)

  • 1. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.
    EDGCOMB JH; ARNOLD J; YOUNT EH; ALVING AS; EICHELBERGER L; JEFFERY GM; EYLES D; YOUNG MD
    J Natl Malar Soc; 1950 Dec; 9(4):285-92. PubMed ID: 14804087
    [No Abstract]   [Full Text] [Related]  

  • 2. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine.
    ALVING AS; HANKEY DD; COATNEY GR; JONES R; COKER WG; GARRISON PL; DONOVAN WN
    Am J Trop Med Hyg; 1953 Nov; 2(6):970-6. PubMed ID: 13104805
    [No Abstract]   [Full Text] [Related]  

  • 3. Cure of Korean vivax malaria with pamaquine and primaquine.
    GARRISON PL; HANKEY DD; COKER WG; DONOVAN WN; JASTREMSKI B; COATNEY GR; ALVING AS; JONES R
    J Am Med Assoc; 1952 Aug; 149(17):1562-3. PubMed ID: 14945979
    [No Abstract]   [Full Text] [Related]  

  • 4. Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.
    Berman J; Brown T; Dow G; Toovey S
    Malar J; 2018 Nov; 17(1):407. PubMed ID: 30400893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative action of pamaquine naphthoate, quinacrine hydrochloride, and quinine bisulphate in Plasmodium cathemerium infections of the duck.
    WALKER HA; STAUBER LA; RICHARDSON AP
    J Infect Dis; 1948; 82(2):187-96. PubMed ID: 18905218
    [No Abstract]   [Full Text] [Related]  

  • 6. Pamaquin; curative antimalarial activity in vivax malaria.
    BERLINER RW; TAGGART JV
    Fed Proc; 1946; 5(1 Pt 2):165. PubMed ID: 21064280
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel.
    Nasveld P; Kitchener S; Edstein M; Rieckmann K
    Trans R Soc Trop Med Hyg; 2002; 96(6):683-4. PubMed ID: 12625150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.
    ALVING AS; JOHNSON CF; TARLOV AR; BREWER GJ; KELLERMEYER RW; CARSON PE
    Bull World Health Organ; 1960; 22(6):621-31. PubMed ID: 13793053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine.
    ALVING AS; ARNOLD J; HOCKWALD RS; CLAYMAN CB; DERN RJ; BEUTLER E; FLANAGAN CL
    J Lab Clin Med; 1955 Aug; 46(2):301-6. PubMed ID: 13242948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemoglobin (methemoglobin) formation in man in plasmochin administration].
    FISCHBACH E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1951; 212(3-4):284-90. PubMed ID: 14820115
    [No Abstract]   [Full Text] [Related]  

  • 12. Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily.
    JONES R; JACKSON LS; DI LORENZO A; MARX RL; LEVY BL; KENNY EC; GILBERT M; JOHNSTON MN; ALVING AS
    Am J Trop Med Hyg; 1953 Nov; 2(6):977-82. PubMed ID: 13104806
    [No Abstract]   [Full Text] [Related]  

  • 13. Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days.
    DI LORENZO A; MARX RL; ALVING AS; JONES R
    Am J Trop Med Hyg; 1953 Nov; 2(6):983-4. PubMed ID: 13104807
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S; Nasveld P; Edstein MD
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of vivax malaria treated with primaquine and report of one case of cyanosis (methemoglobinemia) due to primaquine.
    HANSEN JE; CLEVE EA; PRUITT FW
    Am J Med Sci; 1954 Jan; 227(1):9-12. PubMed ID: 13114209
    [No Abstract]   [Full Text] [Related]  

  • 18. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
    Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
    Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.